Literature DB >> 6104683

Hemagglutination and colonization factors in enterotoxigenic and enteropathogenic Escherichia coli that cause diarrhea.

M M Levine, M B Rennels, V Daya, T P Hughes.   

Abstract

Controversy exists as to whether all strains of enterotoxigenic Escherichia coli must possess colonization factor antigen pili I or II (CFA/I, CFA/II) in order to be virulent for humans. Failure to detect CFA/I or CFA/II in enterotoxigenic strains from human diarrhea has been explained by some as due to plasmid loss and by others as evidence that CFA/I and CFA/II pili are not prerequisites for human virulence in all enterotoxigenic strains of E. coli. Seven enterotoxigenic and three enteropathogenic strains of E. coli that have been used in volunteer challenge studies were tested for CFA/I, CFA/II, and type 1 somatic pili after culture on solid agar and in broth. Six of the seven enterotoxigenic and two of the three enteropathogenic strains caused diarrhea in humans. Of these eight virulent strains, one produced CFA/I, and one had CFA/II. Threre remained four enterotoxigenic and two enteropathogenic strains that unequivocally caused diarrhea while lacking CFA/I or CFA/II. In such strains other organelles or surface properties must be operative to promote adhesion to and colonization of small intestinal mucosa. CFA/I and CFA/II are not prerequisites of virulence for all E. coli strains that cause diarrhea in humans.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6104683     DOI: 10.1093/infdis/141.6.733

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  30 in total

1.  Design and characterization of highly immunogenic heat-stable enterotoxin of enterotoxigenic Escherichia coli K99(+).

Authors:  Nasr-Eldin M Aref; A Mahdi Saeed
Journal:  J Immunol Methods       Date:  2011-01-28       Impact factor: 2.303

2.  Role of Escherichia coli type 1 pilus in colonization of porcine ileum and its protective nature as a vaccine antigen in controlling colibacillosis.

Authors:  H G Jayappa; R A Goodnow; S J Geary
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

3.  Adhesion of enteropathogenic Escherichia coli to human intestinal enterocytes and cultured human intestinal mucosa.

Authors:  S Knutton; D R Lloyd; A S McNeish
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

Review 4.  Host-specific fimbrial adhesins of noninvasive enterotoxigenic Escherichia coli strains.

Authors:  W Gaastra; F K de Graaf
Journal:  Microbiol Rev       Date:  1982-06

5.  Role of plasmid-encoded adherence factors in adhesion of enteropathogenic Escherichia coli to HEp-2 cells.

Authors:  S Knutton; M M Baldini; J B Kaper; A S McNeish
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

6.  Hemagglutination activity and colonization factor antigens I and II in enterotoxigenic and non-enterotoxigenic strains of Escherichia coli isolated from humans.

Authors:  A Cravioto; S M Scotland; B Rowe
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

7.  Colonization antigens and haemagglutination patterns of human Escherichia coli.

Authors:  J Blanco; E A González; R Anadón
Journal:  Eur J Clin Microbiol       Date:  1985-06       Impact factor: 3.267

8.  New fimbrial antigenic type (E8775) that may represent a colonization factor in enterotoxigenic Escherichia coli in humans.

Authors:  L V Thomas; A Cravioto; S M Scotland; B Rowe
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

9.  Pilus production, hemagglutination, and adhesion by porcine strains of enterotoxigenic Escherichia coli lacking K88, K99, and 987P antigens.

Authors:  M Awad-Masalmeh; H W Moon; P L Runnels; R A Schneider
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

10.  Glycans of bovine lactoferrin function as receptors for the type 1 fimbrial lectin of Escherichia coli.

Authors:  S Teraguchi; K Shin; Y Fukuwatari; S Shimamura
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.